N-6-HB-426-20

N/A

Report date: 2022/07/01 15:29:28

Base Information

Drug NameN-6-HB-426-20
Drug Alias NameN6HB426-20N-6-HB-426-20
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody
Mechanisms of ActionSodium/bile acid cotransporter inhibitors
TargetsSodium/bile acid cotransporter
Therapy Area/IndicationsHepatitis B
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryJapan
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesRiken
China Registration ClassN/A

Develop Information

Active CompaniesRiken
Inactive CompaniesN/A
Active IndicationsHepatitis B
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A